Skip to main content
    T

    Tenax Therapeutics Inc (TENX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.42
    -0.06 (-4.05%)

    Market Cap: $73.77M

    Last updated: Nov 17, 2026 at 4:25 PM ET

    Tenax Therapeutics Inc (TENX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Tenax Therapeutics (TENX) has a market cap of $73.77M. Its share count is up 34.50% from a year earlier. It holds $113.73M more cash than debt, 154.17% of its market cap.

    Total Valuation

    Market Cap$73.77M
    Latest price (Nov 17, 2026)$1.42

    Key Dates

    The next earnings report is expected on Mar 8, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 8, 2027 (expected)
    Last Earnings DateNov 5, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 5.08% in the quarter ended Sep 30, 2026 and grew 58.93% a year over 2 years.

    Shares Outstanding53.45M
    Shares Change (YoY)+34.50%
    Shares Change (QoQ)+5.08%
    Share Count Growth (2Y CAGR)+58.93%

    Price Statistics

    The stock is down 80.00% over 52 weeks and trades 19.77% below its 50-day average.

    Beta (1Y)1.32
    52-Week Change-80.00%
    1-Month Change-6.58%
    3-Month Change-25.26%
    6-Month Change-87.63%
    5-Year Change-99.93%
    10-Year Change-100.00%
    Total Return (1Y)-80.00%
    Total Return (3Y CAGR)-64.02%
    Total Return (5Y CAGR)-76.64%
    Return vs SPY (1Y)-93.08%
    Max Drawdown (1Y)-92.58%
    Max Drawdown (3Y)-95.76%
    Sharpe Ratio (1Y)-0.69
    Correlation with SPY (1Y)0.07
    50-Day Average$1.77
    200-Day Average$9.29
    52-Week Range$1.31 to $19.40
    RSI (14 Days)33.4
    Average Volume (20 Days)1.47M

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 14.01x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio14.01x
    Quick Ratio14.01x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -60.52% and return on assets is -56.20% over the last 12 months.

    Return on Equity (ROE)-60.52%
    Return on Assets (ROA)-56.20%

    Scores

    TENX has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue of $0 over the last 12 months is down 100.00% from the 12 months before.

    Revenue$0
    Revenue Growth (YoY)-100.00%
    Operating Income-$69.53M
    Pretax Income-$65.76M
    Net Income-$65.76M
    Reported EPS (TTM)-$1.39

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 92.86% of the $117.01M in total assets.

    Cash and Equivalents$113.73M
    Total Debt$0
    Net Cash$113.73M
    Net Cash Per Share$2.13
    Working Capital$108.66M
    Shareholder Equity$108.66M
    Book Value Per Share$2.03
    Total Assets$117.01M
    Total Liabilities$8.36M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $0 of capital spending, operating cash flow left -$49.35M of free cash flow.

    Operating Cash Flow-$49.35M
    Capital Expenditures$0
    Free Cash Flow-$49.35M
    FCF Per Share-$1.08

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Dividends and Yields

    TENX does not pay a dividend. Its free cash flow yield is -65.02%.

    FCF Yield-65.02%
    Shareholder Yield0.00%

    Stock Splits

    The last split was a 1-for-80 reverse split on Jan 3, 2024.

    Last Split DateJan 3, 2024
    Split TypeReverse split
    Split Ratio1:80

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TENX

    What is TENX's market cap?

    Tenax Therapeutics has a market cap of $73.77M.

    How many shares of TENX are outstanding?

    Tenax Therapeutics has 53.45M shares outstanding. The count is up 34.50% from a year earlier.

    Does TENX pay a dividend?

    No. Tenax Therapeutics does not pay a dividend.

    How much debt does TENX have?

    Tenax Therapeutics has $0 of total debt and $113.73M of cash and equivalents, a net cash position of $113.73M.